Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Quince Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- +2 vs. Q4 2024
- Shares held
- 5.23M
- +946.0K (+22.1%) vs. Q4 2024
- Total value
- $6.96M
- −$1.05M (−13.2%) vs. Q4 2024
- New holders
- 7
- 9 more added
- Sold out
- 5
- 9 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 23 | $30 | 0.00% | −77−77.0% | Reduced |
| FMR LLC | 50 | $67 | 0.00% | +50 | New |
| SBI Securities Co., Ltd. | 74 | $98 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $100 | 0.00% | 00.0% | Unchanged |
| Hurley Capital, LLC | 121 | $161 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 246 | $327 | 0.00% | +246 | New |
| Advisor Group Holdings, Inc. | 277 | $368 | 0.00% | −505−64.6% | Reduced |
| Parallel Advisors, LLC | 295 | $392 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $452 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 547 | $728 | 0.00% | +2+0.4% | Added |
| UBS Group AG | 706 | $939 | 0.00% | −408−36.6% | Reduced |
| Bank of America Corp | 2,844 | $3.78K | 0.00% | −185−6.1% | Reduced |
| Nixon Peabody Trust Co | 11,126 | $14.8K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 14,613 | $19.0K | 0.00% | −5,619−27.8% | Reduced |
| Anfield Capital Management, LLC | 30,227 | $40.2K | 0.01% | +3,571+13.4% | Added |
| Gsa Capital Partners LLP | 36,627 | $49.0K | 0.00% | +36,627 | New |
| Citadel Advisors LLC | 40,397 | $53.7K | 0.00% | +40,397 | New |
| Two Sigma Investments, LP | 41,150 | $54.7K | 0.00% | +10,809+35.6% | Added |
| Virtu Financial LLC | 43,332 | $58.0K | 0.00% | +14,128+48.4% | Added |
| Intellectus Partners, LLC | 53,312 | $70.9K | 0.02% | +53,312 | New |
| Morgan Stanley | 53,574 | $71.3K | 0.00% | −23,127−30.2% | Reduced |
| Northern Trust Corp | 77,492 | $103.1K | 0.00% | +26,968+53.4% | Added |
| Scharf Investments, LLC | 91,061 | $121.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 106,417 | $141.5K | 0.00% | +14,100+15.3% | Added |
| Mariner, LLC | 122,461 | $162.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 124,911 | $166.1K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 142,958 | $190.1K | 0.04% | 00.0% | Unchanged |
| Shay Capital LLC | 184,334 | $245.2K | 0.07% | −92,465−33.4% | Reduced |
| Tang Capital Management LLC | 184,383 | $245.2K | 0.01% | +184,383 | New |
| Alphabet Inc. | 189,122 | $251.5K | 0.02% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 343,570 | $456.9K | 0.00% | +2,000+0.6% | Added |
| BlackRock, Inc. | 345,448 | $459.4K | 0.00% | −102,285−22.8% | Reduced |
| Geode Capital Management, LLC | 395,710 | $526.4K | 0.00% | +19,778+5.3% | Added |
| Renaissance Technologies LLC | 499,907 | $664.9K | 0.00% | −23,143−4.4% | Reduced |
| Ieq Capital, LLC | 806,780 | $1.07M | 0.01% | +806,780 | New |
| Vanguard Group Inc | 1,285,773 | $1.71M | 0.00% | +13,433+1.1% | Added |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −15,359−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,475−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −5,165−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,697−100.0% | Sold out |
| Financial Avengers, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| EPIQ Capital Group, LLC | – | – | – | – | Not filed |